ファージディスプレイライブラリー
WordNet
- attract attention by displaying some body part or posing; of animals
- something shown to the public; "the museum had many exhibits of oriental art" (同)exhibit, showing
- a visual representation of something (同)presentation
- an electronic device that represents information in visual form (同)video display
- something intended to communicate a particular impression; "made a display of strength"; "a show of impatience"; "a good show of looking interested" (同)show
- behavior that makes your feelings public; "a display of emotion"
- exhibiting openly in public view; "a display of courage"
PrepTutorEJDIC
- 〈物〉‘を'『展示する』,陳列する(exhibit) / 〈感情など〉‘を'『表に出す』;〈能力など〉‘を'発揮する / …‘を'見せびらかす,誇示する(show off) / (…を)『見せること』;(感情などを)表に出すこと;(能力などの)発揮《+『of』+『名』》 / 『誇示』,見せびらかし / (商品・作品などの)『展示』,陳列《+『of』+『名』》;展示品
- =bacteriophage
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines.
- Hanes MS1, Salanga CL1, Chowdry AB1, Comerford I2, McColl SR2, Kufareva I1, Handel TM3.
- The Journal of biological chemistry.J Biol Chem.2015 Sep 11;290(37):22385-97. doi: 10.1074/jbc.M115.675108. Epub 2015 Jul 27.
- The chemokine CXCL12 and its G protein-coupled receptors CXCR4 and ACKR3 are implicated in cancer and inflammatory and autoimmune disorders and are targets of numerous antagonist discovery efforts. Here, we describe a series of novel, high affinity CXCL12-based modulators of CXCR4 and ACKR3 generate
- PMID 26216880
- Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
- Lehmann A, Wixted JH, Shapovalov MV, Roder H, Dunbrack RL Jr, Robinson MK.
- mAbs.MAbs.2015 Sep 4:0. [Epub ahead of print]
- Phage-display technology facilitates rapid selection of antigen-specific single-chain variable fragment (scFv) antibodies from large recombinant libraries. ScFv antibodies, composed of a VH and VL domain, are readily engineered into multimeric formats for the development of diagnostics and targeted
- PMID 26337947
- Preferential germline usage and VH/VL pairing observed in human antibodies selected by mRNA display.
- Chen L1, Kutskova YA1, Hong F1, Memmott JE1, Zhong S1, Jenkinson MD1, Hsieh CM2.
- Protein engineering, design & selection : PEDS.Protein Eng Des Sel.2015 Sep 2. pii: gzv042. [Epub ahead of print]
- Since the invention of phage display, in vitro antibody display technologies have revolutionized the field of antibody discovery. In combination with antibody libraries constructed with sequences of human origin, such technologies enable accelerated therapeutic antibody discovery while bypassing the
- PMID 26337062
Japanese Journal
- Single-Chain Antibodies (ScFv) Specific to the Narcotics Isolated from Immune Phage Libraries
- MATSUKIZONO Miho,KAMEGAWA Mariko,TANAKA Koichi,KOHRA Shinya,ARIZONO Koji,HAMAZOE Yuta,SUGIMURA Kazuhisa
- Peptide science : proceedings of the ... Japanese Peptide Symposium 2011, 263-264, 2012-03-01
- NAID 10030204380
- Identification of Novel Short Peptide Inhibitors of Soluble 37/48kDa Oligomers of Amyloid β42
- KAWASAKI Takayasu,ONODERA Kenji,KAMIJO Shunsuke
- Bioscience, biotechnology, and biochemistry 75(8), 1496-1501, 2011-08-23
- … We have found by phage display that a 7-residue peptide, SRPGLRR, exhibited inhibitory activity against soluble 37/48 kDa oligomers of Aβ42. … In the present study, we newly prepared 3- and 4-residue random peptides libraries and performed pannings of them against soluble Aβ42 to search for important factors in the inhibition of Aβ42 oligomerization. … After the fifth round, arginine-containing peptides were enriched in both libraries. …
- NAID 10029591398
Related Pictures
★リンクテーブル★
[★]
- 英
- phage display libraries
[★]
- 関
- demonstrate、demonstration、denote、depict、exhibit、exhibition、give、indicate、indication、indicative、label、point out、present、reflect、representation、show、signify、suggest
[★]
ファージディスプレイ、ファージ提示法、ファージディスプレイ法
[★]
- 関
- bacteriophage